Resources from the same session
LBA4 - Dynamic immune compartment remodeling in response to durvalumab in the POP-DURVA study: Comprehensive Profiling using spectral cytometry and multiplex immunohistochemistry
Presenter: Joana Ribeiro
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
170MO - Tremelimumab +/- durvalumab plus paclitaxel as immune induction in metastatic urothelial cancer: translational results of the ICRA trial
Presenter: Hamza Ali
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
171MO - Unraveling iCAF and tumor cell communication: Advancing novel adjuvant immunotherapy response and prognostic prediction via single-cell analysis and multimodal data-based models
Presenter: Wei Ren
Session: Mini Oral session 1
Resources:
Abstract
172MO - Novel regulators of antigen presentation and therapeutic reactivation of MHC-I to overcome immune evasion in small cell lung cancer
Presenter: Triparna Sen
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
173MO - Immunological dynamics of HLA-II positive melanoma
Presenter: Mario Presti
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
3MO - LDH isoforms shape the immune microenvironment and impact treatment response and survival in metastatic melanoma
Presenter: Laura Soumoy
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 172MO, 173MO, and 3MO
Presenter: Aurélien Marabelle
Session: Mini Oral session 1
Resources:
Slides
Webcast
174MO - The A2AR antagonist inupadenant promotes humoral responses in patients
Presenter: Hussein Shehade
Session: Mini Oral session 1
Resources:
Abstract
4MO - Role of ctDNA tumor fraction to select immunotherapy based regimens in advanced non-small cell lung cancer
Presenter: Filippo Dall'Olio
Session: Mini Oral session 1
Resources:
Abstract
5MO - Novel radiologic phenotypes of chaotic tumor angiogenesis associated with poor ICI outcomes in NSCLC
Presenter: Vamsidhar Velcheti
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast